DE LA ROSA, Olga,LOMBARDO, Eleuterio,DALEMANS, Wilfried
申请号：
AU2020200807
公开号：
AU2020200807A1
申请日:
2020.02.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020200807A120200220.pdf#####Abstract The present invention provides a method for determining the clinical prognosis of a human subject to the administration of a pharmaceutical composition comprising of stem cells (preferably mesenchymal stem 5 cells), stromal cells, regulatory T-cells, fibroblasts and combinations thereof.
